Contacts, documents and full notice history are available with a subscription.
Presolicitation NONE Expired 1 notice

Agilent NovoCyte Advanteon Flow Cytometer 75N98026Q00590

Solicitation 75N98026Q00590 Copied Notice ID eee2f699f0724013ba30903f8399b100 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — NATIONAL INSTITUTES OF HEALTH OLAO
SAM.gov
Posted
Jun 10, 2026
Deadline
Jun 22, 2026
Set-aside
NONE
NAICS
334516
PSC
6640

Summary

AI-generated · Jun 11, 2026

Acquisition of the NovoCyte Advanteon Flow Cytometer, a benchtop system designed for high-parameter cellular analysis in research and clinical laboratory settings. It is a multicolor flow cytometry platform with flexible hardware configurations and automated data acquisition and analysis capabilities.

This instrument will support studies on how gene expression is regulated by RNA-binding proteins and microRNAs, which are important for understanding disruptions in diseases such as cancer, hearing loss, and diabetes and for developing new therapeutic approaches. Using this system is expected to significantly increase experimental throughput and improve the efficiency of research workflows for these projects.

The NovoCyte Advanteon Flow Cytometer is a benchtop system designed for high-parameter cellular analysis in research and clinical laboratory settings. It is an advanced platform for multicolor flow cytometry that combines flexible hardware configurations with automated data acquisition and analysis capabilities. The Section on Regulatory Ribonucleic Acids conducts research on the regulation of gene expression by ribonucleic acid binding proteins and micro ribonucleic acids. These studies are critical to understanding how gene regulation is disrupted in diseases such as cancer, hearing loss, and diabetes. Understanding these processes supports the development of new therapeutic approaches. Acquisition of the NovoCyte Advanteon Flow Cytometer will significantly increase experimental throughput and improve the efficiency of research workflows supporting these projects.

From Presolicitation posted on Jun 10, 2026

Notice history

1
  1. Presolicitation LATEST Posted Jun 10, 2026 View

Details

Solicitation number 75N98026Q00590
Notice ID eee2f699f0724013ba30903f8399b100
Notice type Presolicitation
Product / Service (PSC) 6640
NAICS 334516
Set-aside No Set aside used
Place of performance Bethesda, Maryland
Archive date Jul 07, 2026

Award Information

Not yet awarded

Documents

No files available

View on SAM.gov

Contacts

primary
LAW, JAMES B

Email

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTES OF HEALTH OLAO

Place of Performance

Bethesda, Maryland 20892
USA

Dates

Posted Jun 10, 2026 1 month ago
Last Updated Aug 06, 2026 2 days ago
Due Jun 22, 2026 1 month ago